Pharma IP Circle

On Nov 30, 2016, The Court of Appeal (UK) handed down judgment in the  Hospira v Genentech  case related to Genentech’s blockbuster drug t...

On Aug 26, 2016, UK Intellectual Property Office rejected the Supplementary Protection Certificate (SPC) application filed by Abraxis BioS...

On Dec 12, 2016, US appeals court upheld the district court decision that the  7,722,898  and  7,910,131  patents are valid and infringed b...

On Nov 21, 2016, the U.S. Court of Appeals for the First Circuit upheld a 2014 jury verdict for AstraZeneca (AZ) and Ranbaxy regarding a ...

On Nov 08, 2016, Indian patent office by its decision on pre-grant opposition rejected Pfizer’s patent application for Xtandi (Enzalutamid...

On Nov 01, 2016, Court of appeal (UK) handed down its decision in Napp Pharmaceutical Holdings Limited v (1) Dr Reddy's Laboratories (...

On October 6, 2016, FDA published a final rule implementing portions of Title XI of the Medicare Prescription Drug, Improvement, and Moder...